Glaukos (GKOS) Net Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -315.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,018.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 399.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | 3,372.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,372.00 |
| Dec 31, 2025 | -5,337.00 |
| Sep 30, 2025 | 2,647.00 |
| Jun 30, 2025 | 4,681.00 |
| Mar 31, 2025 | -2,497.00 |
| Dec 31, 2024 | 14,084.00 |
| Sep 30, 2024 | -3,049.00 |
| Jun 30, 2024 | -3,044.00 |
| Mar 31, 2024 | -2,347.00 |
| Dec 31, 2023 | 13,754.00 |
| Sep 30, 2023 | -1,472.00 |
| Jun 30, 2023 | 8,565.00 |
| Mar 31, 2023 | 5,083.00 |
| Dec 31, 2022 | 4,298.00 |
| Sep 30, 2022 | -1,554.00 |
| Jun 30, 2022 | -5,188.00 |
| Mar 31, 2022 | 1,047.00 |
| Dec 31, 2021 | -3,602.00 |
| Sep 30, 2021 | 2,342.00 |
| Jun 30, 2021 | -988.00 |
| Mar 31, 2021 | -1,748.00 |
| Dec 31, 2020 | -1,696.00 |
| Sep 30, 2020 | -2,757.00 |
| Jun 30, 2020 | -11,842.00 |
| Mar 31, 2020 | -10,014.00 |
| Dec 31, 2019 | 3,163.00 |
| Sep 30, 2019 | -2,700.00 |
| Jun 30, 2019 | -1,893.00 |
| Mar 31, 2019 | -637.00 |
| Dec 31, 2018 | -16,683.00 |
| Sep 30, 2018 | -409.00 |
| Jun 30, 2018 | 17,062.00 |
| Mar 31, 2018 | 321.00 |
| Dec 31, 2017 | 3,315.00 |
| Sep 30, 2017 | 1,556.00 |
| Jun 30, 2017 | 1,447.00 |
| Mar 31, 2017 | 5,128.00 |